2nd Quarter - Report

WILLIAMS AND JENSEN, PLLC for BAYER CORPORATION

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare payment for diabetes testing strips; drug rebates for Medicare Part D. Independent Payment Advisory Board (IPAB)

LobbyistCovered position, as disclosed
KARINA LYNCH —
GEORGE OLSEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Chemicals/Chemical Industry CHM

Matters concerning safety and security at chemical plants.

LobbyistCovered position, as disclosed
GEORGE OLSEN —
ANTHONY J RODA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Drug safety and drug counterfeiting; Drug importation; 340B Program; Authorized generics; Prescription drug advertising; Federal preemption for prescription drugs; Implementation of Patient Protection and Affordable Care Act; Reauthorization of Prescription Drug User Fee Act and drug shortages (FDA Safety and Innovation Act (S. 3187))

LobbyistCovered position, as disclosed
JENNY DIJAMES New LA and LD, Rep. Bud Cramer
JACK STEVEN HART —
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
KARINA LYNCH —
MELINDA M MAXFIELD New —
GEORGE OLSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3187 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.